Heptanon 5 mg tablete Slovenien - slovensk - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

heptanon 5 mg tablete

pliva ljubljana d.o.o., ljubljana - metadon - tableta - metadon 4,48 mg / 1 tableta - metadon

METADONIJEV KLORID ALKALOID-INT 10 mg/ml peroralna raztopina Slovenien - slovensk - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

metadonijev klorid alkaloid-int 10 mg/ml peroralna raztopina

alkaloid - int d.o.o. - metadon - peroralna raztopina - metadon 8,95 mg / 1 ml - metadon

Heptanon 10 mg/ml peroralna raztopina Slovenien - slovensk - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

heptanon 10 mg/ml peroralna raztopina

pliva ljubljana d.o.o., ljubljana - metadon - peroralna raztopina - metadon 8,95 mg / 1 ml - metadon

Heptanon 10 mg/ml raztopina za injiciranje Slovenien - slovensk - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

heptanon 10 mg/ml raztopina za injiciranje

pliva ljubljana d.o.o., ljubljana - metadon - raztopina za injiciranje - metadon 8,95 mg / 1 ml - metadon

Heptanon 10 mg/ml peroralne kapljice, raztopina Slovenien - slovensk - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

heptanon 10 mg/ml peroralne kapljice, raztopina

pliva ljubljana d.o.o., ljubljana - metadon - peroralne kapljice, raztopina - metadon 8,95 mg / 1 ml - metadon

METADONIJEV KLORID ALKALOID-INT 10 mg/ml peroralne kapljice, raztopina Slovenien - slovensk - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

metadonijev klorid alkaloid-int 10 mg/ml peroralne kapljice, raztopina

alkaloid - int d.o.o. - metadon - peroralne kapljice, raztopina - metadon 8,95 mg / 1 ml - metadon

Lenalidomide Krka (previously Lenalidomide Krka d.d. Novo mesto) Den Europæiske Union - slovensk - EMA (European Medicines Agency)

lenalidomide krka (previously lenalidomide krka d.d. novo mesto)

krka, d.d., novo mesto  - lenalidomide hydrochloride monohydrate - multiple myeloma; myelodysplastic syndromes; lymphoma, follicular; lymphoma, mantle-cell - imunosupresivi - multiple myelomalenalidomide krka as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide krka as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) je indiciran za zdravljenje odraslih bolnikov s predhodno nezdravljenih več plazmocitom, ki niso primerni za presaditev. lenalidomide krka in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. myelodysplastic syndromeslenalidomide krka as monotherapy is indicated for the treatment of adult patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality when other therapeutic options are insufficient or inadequate. mantle cell lymphomalenalidomide krka as monotherapy is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (see sections 4. 4 in 5. follicular lymphomalenalidomide krka in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a). multiple myelomalenalidomide krka as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide krka as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) je indiciran za zdravljenje odraslih bolnikov s predhodno nezdravljenih več plazmocitom, ki niso primerni za presaditev. lenalidomide krka in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. myelodysplastic syndromeslenalidomide krka as monotherapy is indicated for the treatment of adult patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality when other therapeutic options are insufficient or inadequate. mantle cell lymphomalenalidomide krka as monotherapy is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (see sections 4. 4 in 5. follicular lymphomalenalidomide krka in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a).

Dexamethasone 1mg/ml Syrspend Pack 100 ml Slovenien - slovensk - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

dexamethasone 1mg/ml syrspend pack 100 ml

deksametazon - peroralna raztopina - deksametazon 1 mg / 1 ml - deksametazon

DEXAMED 0,5 mg tablete Slovenien - slovensk - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

dexamed 0,5 mg tablete

sanolabor, d.d. - deksametazon - tableta - deksametazon 0,5 mg / 1 tableta - deksametazon

DEXAMETHASON JENAPHARM 0,5 mg tablete Slovenien - slovensk - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

dexamethason jenapharm 0,5 mg tablete

pharmasan d.o.o. - deksametazon - tableta - deksametazon 0,5 mg / 1 tableta - deksametazon